What you pay for a GLP-1: 24 answers by drug and plan

By John Samaras, EditorTerms verified August 10, 2026

24 answers sit behind two questions, one for every drug and payment situation. A commercially insured patient pays as little as $25 a month with a manufacturer savings card, according to GLP Chart, checked August 10, 2026. Every government plan is barred from those cards. Pick your drug and how you pay to see what each route costs and who it shuts out.

Two questions

See what you pay

Nothing you pick here is sent anywhere.

Whatever your plan does, the cash floor is the same: Strut Health is the cheapest cash route on the chart, from $149 a month. That price buys compounded semaglutide, a pharmacy-made version that is not FDA-approved and is not Wegovy, Ozempic, Zepbound or Mounjaro.

Visit Strut Health

Frequently asked questions

Who cannot use a manufacturer savings card?

Anyone on Medicare, Medicaid, TRICARE, VA or any other federal or state health program. Federal anti-kickback law sets that bar and no appeal changes it. All 5 cards still running carry the same exclusion.

Do I need insurance to buy from the maker directly?

No. Novo Nordisk and Eli Lilly both sell direct at published cash prices, and those prices are the same whether or not you have a plan. You still need a prescription.

How current are these numbers?

Card and cash terms carry their own read date, and chart prices carry theirs. Both sit on every answer page, next to the figure they belong to.

GLP Chart is an independent comparison site, not a pharmacy and not a medical provider. Card and cash terms are read at the manufacturer's own page and dated. They can change on any day, so confirm yours before your next fill.

Why you can trust GLP Chart. Same scoring framework applied to every program. No paid placements. We never remove unfavorable information at an advertiser's request. Pricing is pulled from each program's public-facing page every Monday.